Effect of Glucagon-Like Peptide-1(7-36)-Amide on Initial Splanchnic Glucose Uptake and Insulin Action in Humans With Type 1 Diabetes
Article Figures & Tables
Figures
- FIG. 1.
Plasma glucose, insulin, and COOH-peptide concentrations observed during the GLP-1 and saline study days.
- FIG. 2.
Plasma glucagon, growth hormone, and cortisol concentrations observed during the GLP-1 and saline study days.
- FIG. 3.
Intravenous glucose infusion rates necessary to maintain a constant plasma glucose concentration (A) and the rate of intraduodenal glucose delivery (B) during the GLP-1 and saline study days.
- FIG. 4.
Total (A) and intact (7-36) plasma GLP-1 (B) concentrations observed during the GLP-1 and saline study days.
- FIG. 5.
Plasma [6,6-2H2]glucose enrichment and the ratio of [6,6-2H2]glucose to [3-3H]glucose observed during the GLP-1 and saline study days.
- FIG. 6.
Rates of glucose disappearance and endogenous glucose production observed during the GLP-1 and saline study days.
- FIG. 7.
Rates of meal appearance and initial splanchnic glucose uptake with time observed during the GLP-1 and saline study days.
In this Issue
